NCPA: Biden’s drug program will fail if pharmacies are paid too little and too late
CMS’ failure to require timely, sufficient pharmacy reimbursement will lead to closures not seen since the start of Part D and patients will suffer as a result.
Pharmacy
Dr. Reddy's gets lenacapavir license
Dr. Reddy’s has been granted a license to manufacture Lenacapavir and market it for the current approved indication of HIV treatment in HTE adults with multi-drug resistant HIV.
Prime Therapeutics’ Mostafa Kamal becomes PCMA board chair
Kamal succeeds David Joyner, executive vice president of CVS Health and president of CVS Caremark, who completed his term as PCMA’s board chairman.
Camber’s readiness for DSCSA compliance
Camber is fully prepared for DSCSA compliance by November 2024.
Qnovia announces FDA clearance of IND application for lead asset RespiRx Nicotine Inhaler
Phase 1 clinical trial for smoking cessation expected to dose first patient in 4Q 2024.
Thrifty White Health honored at UCare’s “A Salute to Excellence!” awards ceremony
Thrifty White Health receives the Innovation Award.
HRG supports independent pharmacies at NCPA Annual Convention
Additionally, HRG will be exhibiting at NCPA Annual, demonstrating their merchandising tools and branding services designed to aid the success of independent pharmacies
Aetna 2025 Medicare plans focus on most important health needs for members
Backed by the strength of CVS Health.
McKesson launches new cell and gene therapy business, InspiroGene
InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape to ensure patients can access the life-changing treatments they need.
Aurobindo gets FDA approval for cephalexin tablets 250mg and 500mg
Aurobindo Pharma’s, Cephalexin Tablets are an AB-rated generic equivalent to the reference listed drug (RLD), Keflet Tablets, manufactured by Eli Lilly and Co.
John Murphy named president and CEO of AAM
He most recently served as the chief policy officer at the Biotechnology Innovation Organization, where he led BIO’s legal, policy, and international initiatives for the organization’s healthcare portfolio.
NACDS urges FDA, HHS to keep medication access as supply chain pursues DSCSA compliance
This situation jeopardizes patients' access to prescription drugs, through no fault of dispensers.
Study: Prescription shortages led to 1 in 4 Americans skipping doses in 2024
47% say their prescriptions have gotten more expensive over the past five years.
GoodRx now offering neffy at lowest discounted cash price at retail pharmacies
Approved by the Food and Drug Administration in August, neffy is the first needle-free treatment for Type I allergic reactions, including anaphylaxis, offering an innovative alternative to auto-injectors.
Biden-Harris Administration announces investment to integrate mental health and substance use disorder treatment into primary care
$240 million in funding will launch and expand behavioral health care services in 400 Community Health Centers that provide primary care to more than 10 million patients – advancing President Biden’s Unity Agenda
NACDS, member pharmacy executives engage in White House meeting to coordinate preparedness for the fall respiratory illness season and beyond
NACDS member pharmacies recently participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy.